_id
69105b66ccc777a4e85d57f4
Ticker
DLB
Name
Dolby Laboratories
Exchange
NYSE
Address
1275 Market Street, San Francisco, CA, United States, 94103-1410
Country
USA
Sector
Industrials
Industry
Specialty Business Services
Currency
USD
Website
https://www.dolby.com
Description
Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. It also provides DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. It serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
Last Close
67.03
Volume
286214
Current Price
67.64
Change
0.9100402804714299
Last Updated
2025-11-29T12:16:33.321Z
Image
-
Ipo Date
2005-02-17T00:00:00.000Z
Market Cap
6464689664
Next Dividend Date
2025-12-10T00:00:00.000Z
Dividend Frequency
Quarterly
Dividend Rate
0.36
Dividend Yield
2.128917800118273
Sentiment
0.915925
Sentiment Sources
24
Rating
4.5
Target Price
90.5
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
307024000
Cost Of Revenue
39519000
Gross Profit
267505000
Operating Expenses
237828000
Operating Income
29677000
Interest Expense
-
Pretax Income
41668000
Net Income
49332000
Eps
0.5093860355616133
Dividends Per Share
31589000
Shares Outstanding
60845846
Income Tax Expense
-7986000
EBITDA
60380000
Operating Margin
9.666019594559383
Total Other Income Expense Net
11991000
Cash
701893000
Short Term Investments
703000
Receivables
511900000
Inventories
30424000
Total Current Assets
1388261000
Property Plant Equipment
503812000
Total Assets
3227760000
Payables
17840000
Short Term Debt
10384000
Long Term Debt
-
Total Liabilities
595814000
Equity
2622557000
Depreciation
24575000
Change In Working Capital
-12174000
Cash From Operations
122831000
Capital Expenditures
21837000
Cash From Investing
-21912000
Cash From Financing
-64055000
Net Change In Cash
36797000
PE
25.7443
PB
2.4978154678811557
ROE
1.881064930142605
ROA
1.5283664212952635
FCF
100994000
Fcf Percent
0.32894496847152016
Piotroski FScore
4
Health Score
72
Deep Value Investing Score
6
Defensive Investing Score
9
Dividend Investing Score
4
Economic Moat Investing Score
8.8
Garp Investing Score
4.5
Growth Investing Score
3.5
Momentum Investing Score
6
Net Net Investing Score
4
Quality Investing Score
6.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
307024000
Quarters > 0 > income Statement > cost Of Revenue
39519000
Quarters > 0 > income Statement > gross Profit
267505000
Quarters > 0 > income Statement > operating Expenses
237828000
Quarters > 0 > income Statement > operating Income
29677000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
41668000
Quarters > 0 > income Statement > net Income
49332000
Quarters > 0 > income Statement > eps
0.5093860355616133
Quarters > 0 > income Statement > dividends Per Share
31589000
Quarters > 0 > income Statement > shares Outstanding
96846000
Quarters > 0 > income Statement > income Tax Expense
-7986000
Quarters > 0 > income Statement > EBITDA
60380000
Quarters > 0 > income Statement > operating Margin
9.666019594559383
Quarters > 0 > income Statement > total Other Income Expense Net
11991000
Quarters > 0 > balance Sheet > cash
701893000
Quarters > 0 > balance Sheet > short Term Investments
703000
Quarters > 0 > balance Sheet > receivables
511900000
Quarters > 0 > balance Sheet > inventories
30424000
Quarters > 0 > balance Sheet > total Current Assets
1388261000
Quarters > 0 > balance Sheet > property Plant Equipment
503812000
Quarters > 0 > balance Sheet > total Assets
3227760000
Quarters > 0 > balance Sheet > payables
17840000
Quarters > 0 > balance Sheet > short Term Debt
10384000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
595814000
Quarters > 0 > balance Sheet > equity
2622557000
Quarters > 0 > cash Flow > net Income
49654000
Quarters > 0 > cash Flow > depreciation
24575000
Quarters > 0 > cash Flow > change In Working Capital
-12174000
Quarters > 0 > cash Flow > cash From Operations
122831000
Quarters > 0 > cash Flow > capital Expenditures
21837000
Quarters > 0 > cash Flow > cash From Investing
-21912000
Quarters > 0 > cash Flow > cash From Financing
-64055000
Quarters > 0 > cash Flow > net Change In Cash
36797000
Quarters > 0 > ratios > PE
0.5093860355616133
Quarters > 0 > ratios > PB
2.4978154678811557
Quarters > 0 > ratios > ROE
1.881064930142605
Quarters > 0 > ratios > ROA
1.5283664212952635
Quarters > 0 > ratios > FCF
100994000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.32894496847152016
Quarters > 0 > health Score
72
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
315546000
Quarters > 1 > income Statement > cost Of Revenue
44002000
Quarters > 1 > income Statement > gross Profit
271544000
Quarters > 1 > income Statement > operating Expenses
223905000
Quarters > 1 > income Statement > operating Income
47639000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
55516000
Quarters > 1 > income Statement > net Income
46071000
Quarters > 1 > income Statement > eps
0.4754489164086687
Quarters > 1 > income Statement > dividends Per Share
31633000
Quarters > 1 > income Statement > shares Outstanding
96900000
Quarters > 1 > income Statement > income Tax Expense
8974000
Quarters > 1 > income Statement > EBITDA
71490000
Quarters > 1 > income Statement > operating Margin
15.097323369651333
Quarters > 1 > income Statement > total Other Income Expense Net
7877000
Quarters > 1 > balance Sheet > cash
698566000
Quarters > 1 > balance Sheet > short Term Investments
763000
Quarters > 1 > balance Sheet > receivables
501995000
Quarters > 1 > balance Sheet > inventories
32415000
Quarters > 1 > balance Sheet > total Current Assets
1338119000
Quarters > 1 > balance Sheet > property Plant Equipment
511429000
Quarters > 1 > balance Sheet > total Assets
3196001000
Quarters > 1 > balance Sheet > payables
17234000
Quarters > 1 > balance Sheet > short Term Debt
21900000
Quarters > 1 > balance Sheet > long Term Debt
0
Quarters > 1 > balance Sheet > total Liabilities
581750000
Quarters > 1 > balance Sheet > equity
2604733000
Quarters > 1 > cash Flow > net Income
46542000
Quarters > 1 > cash Flow > depreciation
24398000
Quarters > 1 > cash Flow > change In Working Capital
-25478000
Quarters > 1 > cash Flow > cash From Operations
67691000
Quarters > 1 > cash Flow > capital Expenditures
6428000
Quarters > 1 > cash Flow > cash From Investing
-6428000
Quarters > 1 > cash Flow > cash From Financing
-60739000
Quarters > 1 > cash Flow > net Change In Cash
6222000
Quarters > 1 > ratios > PE
0.4754489164086687
Quarters > 1 > ratios > PB
2.5163101170062347
Quarters > 1 > ratios > ROE
1.7687417481945367
Quarters > 1 > ratios > ROA
1.441520199774656
Quarters > 1 > ratios > FCF
61263000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.19414918902473807
Quarters > 1 > health Score
72
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
369561000
Quarters > 2 > income Statement > cost Of Revenue
35837000
Quarters > 2 > income Statement > gross Profit
333724000
Quarters > 2 > income Statement > operating Expenses
221751000
Quarters > 2 > income Statement > operating Income
111973000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
120250000
Quarters > 2 > income Statement > net Income
91793000
Quarters > 2 > income Statement > eps
0.9417467759641329
Quarters > 2 > income Statement > dividends Per Share
31829000
Quarters > 2 > income Statement > shares Outstanding
97471000
Quarters > 2 > income Statement > income Tax Expense
28024000
Quarters > 2 > income Statement > EBITDA
144677000
Quarters > 2 > income Statement > operating Margin
30.29892223475962
Quarters > 2 > income Statement > total Other Income Expense Net
8277000
Quarters > 2 > balance Sheet > cash
750342000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
544466000
Quarters > 2 > balance Sheet > inventories
34594000
Quarters > 2 > balance Sheet > total Current Assets
1389280000
Quarters > 2 > balance Sheet > property Plant Equipment
506749000
Quarters > 2 > balance Sheet > total Assets
3229036000
Quarters > 2 > balance Sheet > payables
17288000
Quarters > 2 > balance Sheet > short Term Debt
10775000
Quarters > 2 > balance Sheet > long Term Debt
0
Quarters > 2 > balance Sheet > total Liabilities
646017000
Quarters > 2 > balance Sheet > equity
2573669000
Quarters > 2 > cash Flow > net Income
92226000
Quarters > 2 > cash Flow > depreciation
24427000
Quarters > 2 > cash Flow > change In Working Capital
33562000
Quarters > 2 > cash Flow > cash From Operations
174897000
Quarters > 2 > cash Flow > capital Expenditures
6897000
Quarters > 2 > cash Flow > cash From Investing
25895000
Quarters > 2 > cash Flow > cash From Financing
-64873000
Quarters > 2 > cash Flow > net Change In Cash
138685000
Quarters > 2 > ratios > PE
0.9417467759641329
Quarters > 2 > ratios > PB
2.561688562126676
Quarters > 2 > ratios > ROE
3.5666202608027686
Quarters > 2 > ratios > ROA
2.84273696545966
Quarters > 2 > ratios > FCF
168000000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.4545934230072978
Quarters > 2 > health Score
75
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
356999000
Quarters > 3 > income Statement > cost Of Revenue
40774000
Quarters > 3 > income Statement > gross Profit
316225000
Quarters > 3 > income Statement > operating Expenses
231129000
Quarters > 3 > income Statement > operating Income
85096000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
86051000
Quarters > 3 > income Statement > net Income
67822000
Quarters > 3 > income Statement > eps
0.6981378735318641
Quarters > 3 > income Statement > dividends Per Share
31548000
Quarters > 3 > income Statement > shares Outstanding
97147000
Quarters > 3 > income Statement > income Tax Expense
17981000
Quarters > 3 > income Statement > EBITDA
111248000
Quarters > 3 > income Statement > operating Margin
23.836481334681608
Quarters > 3 > income Statement > total Other Income Expense Net
955000
Quarters > 3 > balance Sheet > cash
611657000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
560196000
Quarters > 3 > balance Sheet > inventories
31833000
Quarters > 3 > balance Sheet > total Current Assets
1285799000
Quarters > 3 > balance Sheet > property Plant Equipment
513085000
Quarters > 3 > balance Sheet > total Assets
3158602000
Quarters > 3 > balance Sheet > payables
11550000
Quarters > 3 > balance Sheet > short Term Debt
11426000
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
641574000
Quarters > 3 > balance Sheet > equity
2507966000
Quarters > 3 > cash Flow > net Income
68070000
Quarters > 3 > cash Flow > depreciation
25197000
Quarters > 3 > cash Flow > change In Working Capital
-12922000
Quarters > 3 > cash Flow > cash From Operations
106779000
Quarters > 3 > cash Flow > capital Expenditures
6779000
Quarters > 3 > cash Flow > cash From Investing
-8141000
Quarters > 3 > cash Flow > cash From Financing
-57571000
Quarters > 3 > cash Flow > net Change In Cash
33905000
Quarters > 3 > ratios > PE
0.6981378735318641
Quarters > 3 > ratios > PB
2.6200606706789484
Quarters > 3 > ratios > ROE
2.704263135943629
Quarters > 3 > ratios > ROA
2.1472157619098575
Quarters > 3 > ratios > FCF
100000000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.28011282944770155
Quarters > 3 > health Score
74
Valuation > metrics > PE
25.7443
Valuation > metrics > PB
2.4978154678811557
Valuation > final Score
79.10684
Valuation > verdict
1.5% Overvalued
Profitability > metrics > ROE
1.881064930142605
Profitability > metrics > ROA
3.5535104710137357
Profitability > metrics > Net Margin
0.16067799259992704
Profitability > final Score
39
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.22718819838806173
Risk > metrics > Interest Coverage
1.5859876015391192
Risk > final Score
66
Risk > verdict
High
Liquidity > metrics > Current Ratio
49.18725198412698
Liquidity > metrics > Quick Ratio
48.109304138321995
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
36
Prev Profitabilities > 1
57
Prev Profitabilities > 2
50
Prev Risks > 0
72
Prev Risks > 1
78
Prev Risks > 2
74
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-11T00:52:49.987Z
Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. It also provides DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. It serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
0.36Next Payout:
Dec 10, 2025Yield:
2.1289 %Dolby Laboratories (DLB): Assessing Valuation After New Home Experience Hub and Tata Motors Dolby Atmos Deal simplywall.st
Read more →(DLB) Movement Within Algorithmic Entry Frameworks news.stocktradersdaily.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$90.5
Analyst Picks
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 66.48% of the total shares of Dolby Laboratories
1.
Vanguard Group Inc(7.881%)
since
2025/06/30
2.
Morgan Stanley - Brokerage Accounts(7.3973%)
since
2025/06/30
3.
BlackRock Inc(6.2804%)
since
2025/06/30
4.
Bank of New York Mellon Corp(5.8271%)
since
2025/06/30
5.
Eaton Vance Atlanta Capital SMID-Cap I(5.0464%)
since
2025/07/31
6.
State Street Corp(2.3591%)
since
2025/06/30
7.
iShares Core S&P Mid-Cap ETF(2.0854%)
since
2025/08/31
8.
Vanguard Total Stock Mkt Idx Inv(1.9888%)
since
2025/07/31
9.
AQR Capital Management LLC(1.8115%)
since
2025/06/30
10.
Geode Capital Management, LLC(1.6241%)
since
2025/06/30
11.
Disciplined Growth Investors Inc(1.6055%)
since
2025/06/30
12.
Vanguard Small Cap Index(1.5509%)
since
2025/07/31
13.
BNY Mellon Dynamic Value Fund A(1.3976%)
since
2025/07/31
14.
Vanguard Information Technology ETF(1.293%)
since
2025/07/31
15.
Frontier Capital Management CO Inc(1.2913%)
since
2025/06/30
16.
First Trust Advisors L.P.(1.2911%)
since
2025/06/30
17.
Mackenzie Investments(1.2125%)
since
2025/06/30
18.
BTIM Corp(1.1458%)
since
2025/06/30
19.
Dimensional Fund Advisors, Inc.(1.1088%)
since
2025/06/30
20.
Snyder Capital Management LP(1.0748%)
since
2025/06/30
21.
Vanguard Small Cap Growth Index Inv(0.8717%)
since
2025/07/31
22.
Schroder Investment Management Group(0.8418%)
since
2025/06/30
23.
Charles Schwab Investment Management Inc(0.7867%)
since
2025/06/30
24.
NORGES BANK(0.7732%)
since
2025/06/30
25.
Grantham, Mayo, Van Otterloo & Co., LLC(0.6967%)
since
2025/06/30
26.
Vanguard Institutional Extnd Mkt Idx Tr(0.6866%)
since
2025/07/31
27.
Fiera Capital Corporation(0.6579%)
since
2025/06/30
28.
Northern Trust Corp(0.635%)
since
2025/06/30
29.
JNL/Newton Equity Income A(0.6096%)
since
2025/06/30
30.
Disciplined Growth - Mid Cap Growth(0.5903%)
since
2024/12/31
31.
First Trust Value Line® Dividend ETF(0.554%)
since
2025/08/28
32.
Canada Life US Small-Mid Cap Growth F(0.5156%)
since
2025/06/30
33.
SPDR® S&P MIDCAP 400 ETF Trust(0.4908%)
since
2025/07/31
34.
First Trust SMID Cp Rising Div Achv ETF(0.4711%)
since
2025/08/28
35.
iShares S&P Mid-Cap 400 Value ETF(0.3495%)
since
2025/08/31
36.
Fidelity Extended Market Index(0.3444%)
since
2025/07/31
37.
Vanguard Dividend Appreciation ETF(0.3356%)
since
2025/07/31
38.
Ninety One American Franchise A Acc£(0.3347%)
since
2025/07/31
39.
Mackenzie US Mid Cap Opportunities F(0.3338%)
since
2025/06/30
40.
Fiera Apex SMID Growth Composite(0.3248%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.